06 jun: Valuta: Euro taber momentum efter Draghi-meldinger
06 jun: ¨KORR: TKD: Kirk & Thorsen Invest køber aktier for 3,7 mio. kr.
06-06-2012 15:29:00

BASF Says Drought-Tolerant Corn's Value to be Determined by Farmers

Relateret indhold
Relateret debat
13 apr - 
https://www.vesselfinder.com/news/9010-Navios-Selects-D..

By Ian Berry

CHICAGO--The makers of the first corn genetically modified to be tolerant of drought said they are confident it will prove its value to farmers despite an environmental group's charge that it provides only modest yield gains.

The drought-tolerant corn, a collaboration between BASF SE (BAS.XE, BASFY) and Monsanto Co. (MON), is being marketed under the DroughtGard brand and is scheduled for widespread introduction in 2013.

It is being tested by 250 farmers this year, and the results will take precedent over the Union of Concerned Scientists' report that was released Tuesday, said Peter Eckes, president of BASF's plant science division.

"Farmers will trust what they see," Eckes said in an interview.

The Union of Concerned Scientists, a frequent critic of genetically modified crops, said the biotech industry has "made little real-world progress" on reducing yield losses from drought.

"Despite many years of research and millions of dollars in development costs, DroughtGard doesn't outperform the non-engineered alternatives," Doug Gurian-Sherman, a senior scientist with the group and author of the report, said in a statement Tuesday.

The group's report suggests that broader efforts to develop genetically modified drought-tolerant traits have slowed and it advocates more public funding for conventional breeding programs. It said DroughtGard, based on limited data, has performed only slightly better than conventionally bred drought-tolerant seeds.

DuPont Co.'s (DD) seed subsidiary, Pioneer Hi-Bred, is already selling a conventionally bred drought-tolerant corn, targeted for parts of the western U.S. Plains, such as Kansas, that are typically drier than the heart of the corn belt further east.

The challenge in creating a genetically modified drought-tolerant seed, the Union of Concerned Scientists said, is that it "requires the interaction of many genes," while genetic engineering can only alter a few genes at a time.

Seed company executives have said drought-tolerant seeds aren't intended to allow farmers to grow corn in the desert, or in the midst of the type of severe drought that plagued the southern U.S. Plains last year.

Eckes said criticism of DroughtGard is based on a "misunderstanding of what the product concept is." The product provides insurance to farmers against yield loss in the event of moderate drought, he said.

BASF, the world's largest chemical company, develops genetically modified crop traits, which it licenses to other companies, such as Monsanto. The German company has a broader collaboration with Monsanto to develop drought-tolerant crops.

Write to Ian Berry at ian.berry@dowjones.com

(END) Dow Jones Newswires

June 06, 2012 09:29 ET (13:29 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

DSV/Nykredit: Kursmål bliver hævet med 8 pct. før regnskab

28-04-2017 14:21:41
Nykredit hæver kursmålet for DSV-aktien til 400 kr. fra 370 kr. forud for transportkoncernens regnskab i næste uge.Banken vurderer, at DSV står stærkt på markedet og kan begynde at fokusere på organisk vækst, efter at det seneste år primært er gået med at integrere amerikanske UTI Worldwide, der blev købt sidste år for 9,5 mia. kr.- Vi har hævet vores estimater for de kommende år. Derudover har vi..

Novo/Nordea: Sanofi-regnskab indikerer lyspunkt på vækstmarkeder

28-04-2017 11:31:07
Kvartalsregnskabet fra Novo Nordisks store franske rival, Sanofi, vidner om, at diabetesforretningen har haft en en stærk udvikling på vækstmarkederne, mens salget er under pres i USA.Og det er en tendens, som Nordea regner med også kan slå igennem i Novos regnskabstal på onsdag. Det fremgår af et notat.Nordea understreger dog, at det langt fra er ligetil at drage paralleller fra Sanofis regnskab...

Novo-rival slår overskuds- og salgsforventninger i første kvartal - NY

28-04-2017 08:06:11
Den franske medicinalvirksomhed Sanofi, der er blandt Novo Nordisks største konkurrenter, er kommet ud af årets første tre måneder med en bedre indtjening end ventet.I første kvartal endte det justerede overskud per aktie (Business EPS, red.) på 1,42 euro, hvilket var højere end de 1,26 euro, som analytikerne ifølge Bloomberg News havde sat næsen op efter.Den samlede omsætning steg til 8,65 mia. e..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge

Relaterede aktiekurser

E.I. du Pont de Nemours .. 79,75 -0,5% Fald i aktiekurs
Monsanto Company 116,61 0,1% Stigning i aktiekurs
Basf SE Basf SE REG SHS 89,32 -0,7% Fald i aktiekurs
Basf N 99,90 0,0% Aktiekurs uændret

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
30. april 2017 18:38:01
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: ReleaseCandidateBuild_20170427.1 - EUROWEB2 - 2017-04-30 18:38:01 - 2017-04-30 18:38:01 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x